🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Many types of cancer are primarily treated with surgery and patient surviva...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2014-10
Trial ID
NCT02234297
Treatments Being Tested
Many types of cancer are primarily treated with surgery and patient surviva...
Status
Completed
Location
Veracity Clinical Research Pty Ltd
Start Date
2013-12
Trial ID
NCT02097875
Treatments Being Tested
Many types of cancer are primarily treated with surgery and patient surviva...
Status
Completed
Location
Chlidren's Hospital Los Angeles
Start Date
2018-11-26
Trial ID
NCT03579602
Treatments Being Tested
Many types of cancer are primarily treated with surgery and patient surviva...
Status
Completed
Location
Seattle Children's
Start Date
2015-06
Trial ID
NCT02462629
Treatments Being Tested
This is the Blaze Bioscience expanded access program for its investigationa...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04343274
Treatments Being Tested
Many types of cancer are primarily treated with surgery and patient surviva...
Status
Withdrawn
Location
Cedars-Sinai Medical Center
Start Date
2015-09
Trial ID
NCT02464332
Treatments Being Tested
The purpose of this study is to examine the use of a single dose of tozuler...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2021-09-30
Trial ID
NCT04743310
Treatments Being Tested
Surgery is the primary treatment modality for many types of cancer and the ...
Status
Completed
Location
Overlake Medical Center
Start Date
2015-07
Trial ID
NCT02496065
Treatments Being Tested
This phase I/II trial studies the side effects of tozuleristide in imaging ...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2024-04-17
Trial ID
NCT05316688
Treatments Being Tested